All News

This award is given to a pharmacist dedicated to improving his or her community, particularly when the vision is related to pharmacy care.

This award honors a pharmacist who leverages pharmacy technology to advance patient care standards, business profitability, or employee productivity.

This award honors a pharmacist who owns a pharmacy in whole or part and demonstrates entrepreneurial spirit in growing its business.

This award honors a military pharmacist who demonstrates an innovative approach to providing care to those who serve our country.

This award honors a pharmacist who excels in providing specialty pharmacy services in a variety of settings.

This award honors a certified pharmacy technician who demonstrates the highest professional standards of patient care.

This award honors a student pharmacist who demonstrates passion for the profession.

This award honors a pharmacist who demonstrates that he or she has made significant contributions to the pharmacy industry.

Bayer HealthCare and Onyx Pharmaceuticals today announced that the FDA has granted Priority Review designation to the supplemental New Drug Application (sNDA) for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer.

A recent webinar from Zitter Health Insights highlighted the role of hubs and how these patient assistance programs are viewed by various stakeholders in the health care space.

An assessment of costs and specialty drug use within 4 chronic conditions found specialty drugs contribute to overall costs for insurance plan members.

As pharmacogenomics continues to progress, specialty pharmacists may dominate treatment for certain diseases.

Immunotherapy, which is based on changes observed at the molecular level, presents an additional treatment option for melanoma that may result in better response rates and, possibly, a cure.

Investigators in Spain have identified a relationship between higher-complexity medication regimens and a lower likelihood of sustained viral response (SVR) after treatment for hepatitis C virus (HCV) infection.

A meta-analysis of studies that examined stimulant use in children diagnosed with brain tumors found that the medication may improve cognitive processes, just as it does for children with ADHD.

Agency aims for consistent biosimilar evaluation procedures, while future in US remains unknown.

The closure of a national network of pharmacies aimed at personalized care and reduced cost elicits questions on the future of pharmacy.

Children who often drink from water bottles with push and pull caps may be more likely to experience recurring ear infections, according to a recent study.

A review of 53 studies finds that hypertension patients with health insurance were more likely to be adherent to antihypertensive medication and to have their hypertension under control than were those without insurance.

Diplomat Specialty Pharmacy, Avella Specialty Pharmacy, EnvisionRxOptions, Prime Therapeutics, BioRx, and Amber Pharmacy were among the top 20 companies producing the largest revenue in the health section of the Inc. list.

Avella Specialty Pharmacy has been named to Inc. Magazine's 500/5000 list of fastest growing companies in America. Avella has been included in this prestigious group of entrepreneurial ventures since Inc. Magazine started the listing in 2006.

Two recent studies shed new light on potential treatments for febrile seizures, the most common seizure form in children younger than 5 years old.

In a new study published in the Journal of Managed Care Pharmacy, investigators interviewed patients and pharmacists about the costs and benefits of obtaining antiretroviral therapies from a community pharmacy.

Although many pharmacies practice compounding, few pharmacy schools teach this skill to students. Should all pharmacy students learn specialized skills?

A pair of recent studies finds that those with a history of cancer have up to a 51% reduced risk of developing Alzheimer's disease.

Diplomat Specialty Pharmacy announced today that Cheryl Allen, RPh, has been promoted to vice president of business development and industry relations.

Despite the high efficacy of imatinib to treat patients with gastrointestinal stromal tumors (GIST), a recent article review of multiple GIST studies reveals that a large number of patients still achieve suboptimal adherence levels.